Your basic understanding of IBX's technology is way off the mark (don't get me started on the antibody theory).
IBX's test is NOT designed as a screening test. We aren't designing some pan-cancer nanomolecule. Not every female will get a MRI using IBX's nanoparticles instead of a mammogram, nor a female who detects a breast lump. They will go down the same diagnosis pathway as before - usually ultrasound then biopsy. If they then received a diagnosis of HER2 positive breast cancer then they may get a MRI + nanoparticle scan to look for lymph node spread. The nanoparticle is highly specific for that type of cancer only, and wouldn't create a signal at other types of cancer.
IBX Price at posting:
1.3¢ Sentiment: Hold Disclosure: Held
